PAXMAN publishes newsletter on positive study results in Japan and its expanded market clearance in Malaysia
Today, PAXMAN publishes the January 2019 issue of its newsletter aimed at shareholders, investors and other interested parties.This issue highlights positive clinical study results with PAXMAN’s scalp cooling in Japan, the world’s second largest medical technology market, as well as a recently received market clearance in Malaysia. With a population of 30 million people, Malaysia has a promising growth potential for PAXMAN in 2019 and beyond. To read the newsletter, and subscribe to receive upcoming issues, follow this link:http://bit.ly/paxmanjanen PAXMAN’s investor newsletter is